Quick Answer
Traws Pharma, Inc. reported Total Assets of $24.96 million for fiscal year 2024.
Traws Pharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $24.96M | +10.0% |
| 2023 | $22.68M | -42.4% |
| 2022 | $39.37M | -29.0% |
| 2021 | $55.48M | +177.6% |
| 2020 | $19.99M | -15.6% |
| 2019 | $23.67M | +32.1% |
| 2018 | $17.92M | +260.0% |
| 2017 | $4.98M | -78.6% |
| 2016 | $23.23M | -0.9% |
| 2015 | $23.45M | -50.5% |
| 2014 | $47.34M | -55.0% |
| 2013 | $105.15M | +25.4% |
| 2012 | $83.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.44M | +39.2% | -20.3% |
| June 30, 2025 | $15.62M | -16.4% | -18.1% |
| March 31, 2025 | $19.06M | +4.9% | -23.6% |
| December 31, 2024 | $24.96M | +10.0% | +179.3% |
| September 30, 2024 | $8.94M | -67.0% | -52.2% |
| June 30, 2024 | $18.69M | -38.7% | +2.8% |
| March 31, 2024 | $18.17M | -48.2% | -19.9% |
| December 31, 2023 | $22.68M | -42.4% | -16.1% |
- Traws Pharma, Inc. showed an increase of +10.0% in Total Assets compared to the prior fiscal year.
- Over the 2012–2024 period, Traws Pharma, Inc.’s total assets has declined by 70.2% (from $83.85 million to $24.96 million).
- The most recent figure is from Traws Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: